MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0100501
Sgpharma Global Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹64.31 Lakh
▲ 4077% YoY
Net profit · FY 2025
₹59,426
Net margin 0.9%
EBITDA · FY 2025
₹30.16 Lakh
EBITDA margin 46.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.6 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Sgpharma Global Private Limited
Data last updated:
Sgpharma Global Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC350222.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.6 Lakh. It is led by directors Chetan Kiritkumar Bhagat and Bhavesh Kiritkumar Bhagat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 Plot 542 3 Bhuta Niwas Dr. Ambedkar Road Matunga Mumbai 400019, Maharashtra, India – 400019.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.31 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹59,426 (net margin 0.9%) and EBITDA of ₹30.16 Lakh (EBITDA margin 46.9%).
Sgpharma Global Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0100501). For more details, the company can be reached via its website sgpharma.com.
Company Details of Sgpharma Global Private Limited
CIN U24290MH2020PTC350222
Registration Number 350222
Incorporation Date 17 November 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0100501
Recognitions & Rankings of Sgpharma Global
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address10 Plot 542 3 Bhuta Niwas Dr. Ambedkar Road Matunga Mumbai 400019, Maharashtra, India – 400019
- IndustryPharma, Pharma Contract R&D
Comprehensive company report
Sgpharma Global Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Sgpharma Global Private Limited
The main business activity of Sgpharma Global is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sgpharma Global Private Limited FY 2025 filings available
Sgpharma Global Private Limited reported revenue of ₹64.31 Lakh (up 4077% YoY) for FY 2025.
Revenue · FY 2025
₹64.31 Lakh ▲ 4077%
Net profit · FY 2025
₹59,426 margin 0.9%
EBITDA · FY 2025
₹30.16 Lakh margin 46.9%
Financial Statement Summary of Sgpharma Global Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹30.16 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹59,426 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sgpharma Global Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 46.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sgpharma Global are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sgpharma Global Private Limited
Sgpharma Global has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetan Kiritkumar Bhagat Also directs: Sgpharma Private Limited | Director | 17 Nov 2020 | 5 Years 11 Months | Current |
| Bhavesh Kiritkumar Bhagat Also directs: Sgpharma Private Limited | Director | 17 Nov 2020 | 5 Years 11 Months | Current |
Peer Comparison of Sgpharma Global Private Limited
Sgpharma Global Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leintz Pharmaceuticals and Chemicals Private Limited | ₹69.21 Lakh (FY 2018) | •••• | •••• | 24.0% | •••• | Bangalore, Karnataka, India |
| Ergam Life Sciences Private Limited | ₹67.84 Lakh (FY 2024) | •••• | •••• | -41.0% | •••• | Hyderabad, Telangana, India |
| Stereo Labs Private Limited | ₹67.46 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
| Jansat Labs Private Limited | ₹67.07 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Hyderabad, Telangana, India |
| Positive Fertility Foundation | ₹65.09 Lakh (FY 2025) | •••• | •••• | 222.0% | •••• | Secunderabad, Telangana, India |
| Sgpharma Global Private Limited this company | ₹64.31 Lakh (FY 2025) | •••• | •••• | 4077.0% | •••• | Mumbai, Maharashtra, India |
| Synflix Pharmaceutical Private Limited | ₹63.52 Lakh (FY 2025) | •••• | •••• | 139.0% | •••• | Chennai, Tamil Nadu, India |
| Tara Lifescience Private Limited | ₹62.02 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Nagpur, Maharashtra, India |
| Edhaa Innovations Private Limited | ₹61.97 Lakh (FY 2025) | •••• | •••• | 77.0% | •••• | Nashik, Maharashtra, India |
| Icomply Lifescience Solutions Private Limited | ₹61.95 Lakh (FY 2024) | •••• | •••• | 99.0% | •••• | Chengalpattu, Tamil Nadu, India |
| Bio-Clinaarc Private Limited | ₹61.19 Lakh (FY 2025) | •••• | •••• | -20.0% | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Sgpharma Global by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Sgpharma Global Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sgpharma Global Private Limited
Sgpharma Global Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sgpharma Global Private Limited
Sgpharma Global Private Limited has a workforce of 0 employees as of Apr 01, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sgpharma Global Private Limited
Sgpharma Global Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bhavesh Kiritkumar Bhagat was appointed as Director on 17 Nov 2020.
AGM
Sgpharma Global Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sgpharma Global Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Bhavesh Kiritkumar Bhagat was appointed as Director.
Appointed
Chetan Kiritkumar Bhagat was appointed as Director.
Incorporation
17 Nov 2020
Sgpharma Global Private Limited was registered on 17 Nov 2020 with Roc Mumbai I & aged 5 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Sgpharma Global Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sgpharma Global Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sgpharma Global Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sgpharma Global Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sgpharma Global Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sgpharma Global Private Limited
Sgpharma Global is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 17 November 2020 (6+ years old) and is registered under CIN U24290MH2020PTC350222.
Sgpharma Global reported revenue of ₹64.31 Lakh for FY 2025 (up 4077% YoY).
Sgpharma Global has 2 current directors:
- Chetan Kiritkumar Bhagat - Director
- Bhavesh Kiritkumar Bhagat - Director
Sgpharma Global reported a net profit of ₹59,426 (net margin 0.9%) and EBITDA of ₹30.16 Lakh (EBITDA margin 46.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Sgpharma Global is U24290MH2020PTC350222. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sgpharma Global was incorporated on 17 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sgpharma Global by revenue are Leintz Pharmaceuticals and Chemicals Private Limited, Ergam Life Sciences Private Limited, Stereo Labs Private Limited, Jansat Labs Private Limited, Positive Fertility Foundation and 5 more, all in the Pharma industry (Contract Research).
Bhavesh Kiritkumar Bhagat was appointed as Director on 17 Nov 2020. Chetan Kiritkumar Bhagat was appointed as Director on 17 Nov 2020.
Yes, Sgpharma Global is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0100501).
Sgpharma Global can be reached through the website sgpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Sgpharma Global is at 10 Plot 542 3 Bhuta Niwas Dr. Ambedkar Road Matunga Mumbai 400019, Maharashtra, India – 400019.